| Nephros Provides Corporate Update - MedIndia |
|
|
MedIndia Nephros anticipates submitting a new 510(k) application to market its leading-edge hemodiafiltration (HDF) system for end-stage renal disease (ESRD) in the US in the third quarter of 2011 which would be subject to the FDA's standard 90-day review |